FRAZIANO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 22.846
EU - Europa 3.139
AS - Asia 3.099
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 292
AF - Africa 122
OC - Oceania 37
AN - Antartide 1
Totale 30.010
Nazione #
US - Stati Uniti d'America 22.647
SG - Singapore 1.192
IT - Italia 686
CN - Cina 567
DE - Germania 426
RU - Federazione Russa 404
BR - Brasile 363
UA - Ucraina 279
IE - Irlanda 251
VN - Vietnam 246
GB - Regno Unito 222
FR - Francia 219
HK - Hong Kong 215
SE - Svezia 162
SA - Arabia Saudita 143
PL - Polonia 141
JP - Giappone 123
CA - Canada 117
BD - Bangladesh 106
FI - Finlandia 103
IN - India 96
KR - Corea 90
NL - Olanda 64
IR - Iran 42
PK - Pakistan 41
AR - Argentina 37
ID - Indonesia 34
MX - Messico 34
BE - Belgio 32
AU - Australia 31
ZA - Sudafrica 31
ES - Italia 29
JO - Giordania 29
TR - Turchia 28
IQ - Iraq 27
PH - Filippine 24
AT - Austria 22
EG - Egitto 20
EC - Ecuador 18
NG - Nigeria 17
CH - Svizzera 16
CO - Colombia 16
ET - Etiopia 16
IL - Israele 15
MY - Malesia 15
CL - Cile 14
CZ - Repubblica Ceca 13
JM - Giamaica 11
LT - Lituania 11
TH - Thailandia 11
TW - Taiwan 11
PT - Portogallo 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
PE - Perù 8
VE - Venezuela 8
EE - Estonia 7
GR - Grecia 7
GT - Guatemala 7
KG - Kirghizistan 7
RO - Romania 7
TN - Tunisia 7
CR - Costa Rica 6
GH - Ghana 6
KE - Kenya 6
NO - Norvegia 6
EU - Europa 5
HN - Honduras 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
ER - Eritrea 4
MA - Marocco 4
NP - Nepal 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
OM - Oman 3
QA - Qatar 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
HU - Ungheria 2
KZ - Kazakistan 2
LI - Liechtenstein 2
LY - Libia 2
MD - Moldavia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SI - Slovenia 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
Totale 29.709
Città #
Woodbridge 5.608
Wilmington 4.989
Houston 4.666
Ashburn 783
Singapore 693
Fairfield 642
Ann Arbor 548
Chandler 499
San Jose 496
Seattle 262
Jacksonville 251
Council Bluffs 225
Dublin 215
Beijing 209
Rome 195
New York 194
Cambridge 190
Hong Kong 189
Dearborn 164
Medford 161
Los Angeles 135
Jeddah 131
The Dalles 109
Santa Clara 105
Kraków 99
Tokyo 89
Lawrence 76
Ho Chi Minh City 71
Hanoi 66
Milan 65
Dallas 61
Buffalo 54
São Paulo 53
Moscow 52
Munich 46
Menlo Park 44
Mülheim 41
Hamburg 40
Helsinki 40
Orem 36
Lauterbourg 35
Boardman 34
Chicago 33
Denver 33
San Diego 33
Warsaw 33
Atlanta 31
North Bergen 31
Montreal 30
Philadelphia 30
Amman 29
Phoenix 29
London 28
Frankfurt am Main 26
Seoul 26
Toronto 26
Brussels 25
Chennai 23
Nuremberg 22
Brooklyn 20
Guangzhou 19
Jakarta 19
Naples 19
Hefei 18
Johannesburg 18
Mexico City 18
Stockholm 18
Mountain View 17
Cairo 16
Manchester 15
Mumbai 15
Redwood City 15
Rio de Janeiro 15
Amsterdam 14
Minneapolis 14
Poplar 14
San Francisco 14
Boston 13
Madrid 13
Norwalk 12
Belo Horizonte 11
Birmingham 11
Haiphong 11
Las Vegas 11
San Mateo 11
Florence 10
Kunming 10
Lappeenranta 10
Palo Alto 10
Redondo Beach 10
Shanghai 10
Southampton 10
Turin 10
Brisbane 9
Central 9
Columbus 9
Kuala Lumpur 9
Vienna 9
Zhengzhou 9
Baghdad 8
Totale 23.682
Nome #
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 684
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 604
B-Pred, a structure based B-cell epitopes prediction server 555
CD4-8- T-cells increase in MRL/lpr mice treated with thymic factors 533
In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures 531
A new Mycobacterium tuberculosis smooth colony reduces growth inside human macrophages and represses PDIM Operon gene expression. Does an heterogeneous population exist in intracellular mycobacteria? 531
Monosodium urate crystals promote innate anti-mycobacterial immunity and improve BCG efficacy as a vaccine against tuberculosis 499
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 497
Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes 489
Mycobacterium tuberculosis may escape helper T cell recognition by infecting human fibroblasts 487
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 477
Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells 473
In vitro anti Mycobacterium tuberculosis H37Rv activity of Lannea acida A. Rich from Burkina Faso 472
The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanism 471
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo 470
Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells 470
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 467
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis 464
PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis 463
Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages 460
Diagnosis of tuberculosis: Available technologies, limitations, and possibilities 459
Effective anti-tumor immunity induced in mice by a two-step vaccination protocol 458
Lysophosphatidic acid enhances antimycobacterial activity both in vitro and ex vivo 456
Compartmentalization of the redox environment in PC-12 neuronal cells 453
Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis 452
Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer 450
Asymmetric liposomes and uses in medical field thereof 449
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 446
Immunoregulatory compounds 442
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 438
Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes 428
Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection 426
CpG oligodeoxynucleotides promote phospholipase D dependent phagolysosome maturation and intracellular mycobacterial killing in M. tuberculosis infected type II alveolar epithelial cells 426
Role of macrophage phospholipase D in natural and CpG-induced antimycobacterial activity 425
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine 422
CpG oligodeoxynucleotides induce Ca2+-dependent phospholipase D activity leading to phagolysosome maturation and intracellular mycobacterial growth inhibition in monocytes 417
Mycobacterial 19-kDa lipoprotein mediates Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages at early stages of infection 414
Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases 411
Molecular bases for the anti-HIV-1 effect of NO. Commentary 403
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 403
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 401
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 399
Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection 398
Nitric oxide inhibits the HIV-1 reverse transcriptase activity 396
Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice 395
Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection 390
Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance 379
Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement 377
Nitric oxide inhibits HIV-1 replication in human astrocytoma cells 376
Analysis of the shotgun expression library of the Mycobacterium tuberculosis genorne for immunodominant polypeptides: Potential use in serodiagnosis 368
Monocytes/macrophages in HIV infection and tuberculosis 361
Mycobacterium tuberculosis and human macrophage: the bacillus with "environment-sensing" 348
Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts 346
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 344
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29 321
Hydroalcoholic extract from Origanum vulgare induces a combined anti-mycobacterial and anti-inflammatory response in innate immune cells 263
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 253
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 252
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 246
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases 230
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 229
A method permissive to fixation and permeabilization for the multiparametric analysis of apoptotic and necrotic cell phenotype by flow cytometry 228
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 213
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy 209
When PINK is a question: A possible evolutionary trade-off in the Galápagos Pink Land Iguana (Conolophus marthae) 202
Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress 194
25-Hydroxyvitamin D Plasma Levels in Natural Populations of Pigmented and Partially Pigmented Land Iguanas from Galápagos (Conolophus spp.) 170
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 158
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 157
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 156
Rifampicin-liposomes for mycobacterium abscessus infection treatment: intracellular uptake and antibacterial activity evaluation 150
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 148
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 147
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 142
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 136
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 134
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis 133
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 130
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Mycobacterium abscessus: Chitosan or ε-Poly-L-Lysine Decoration 126
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 126
Bioactive liposomes for the control of Mycobacterium abscessus infection. 124
Immunization with mycobacterium tuberculosisantigens encapsulated in phosphatidylserine liposomes improves protection afforded by BCG 116
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 114
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 105
PMN-MDSC frequency discriminates active versus latent tuberculosis and could play a role in counteracting the immune-mediated lung damage in active disease 94
Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages 93
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models 90
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 84
Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance 71
vB_KpM_GP-7: a novel myovirus targeting capsule-deficient, phage-resistant Klebsiella pneumoniae 41
Production and characterization of a phage-encoded capsular polysaccharide endoglycosidase targeting Sequence Type 307 Klebsiella pneumoniae strains 38
Phosphatidylserine liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis non-eligible for CFTR modulators 37
Lytic bacteriophages against Klebsiella pneumoniae and their impact on bacterial virulence 36
Phosphatidylinositol 5-phosphate-loaded-apoptotic body-like liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis 31
Enhanced clearance of phage-resistant Klebsiella pneumoniae strains by the innate immune system 30
Totale 30.010
Categoria #
all - tutte 75.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022812 0 0 0 28 17 69 61 165 76 86 59 251
2022/20231.213 97 110 42 153 150 247 92 73 118 4 88 39
2023/20241.309 68 16 19 157 141 357 151 101 69 50 66 114
2024/20252.258 152 383 230 167 107 193 218 106 214 179 168 141
2025/20264.029 330 227 422 411 408 159 462 466 394 336 286 128
2026/20271.518 176 207 681 454 0 0 0 0 0 0 0 0
Totale 30.010